Sökning: onr:"swepub:oai:DiVA.org:uu-524336" >
Graft-versus-Host D...
-
Ortí, GuillermoVall dHebron Univ Hosp, Vall dHebron Inst Oncol, Dept Hematol, Barcelona, Spain.
(författare)
Graft-versus-Host Disease Prophylaxis with PostTransplantation Cyclophosphamide in Chronic Myeloid Leukemia Patients Undergoing Allogeneic Hematopoietic Cell Transplantation from an Unrelated or Mismatched Related Donor : A Comparative Study from the Chronic Malignancies Working Party of the EBMT (CMWP-EBMT)
- Artikel/kapitelEngelska2024
Förlag, utgivningsår, omfång ...
-
Elsevier,2024
-
printrdacarrier
Nummerbeteckningar
-
LIBRIS-ID:oai:DiVA.org:uu-524336
-
https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-524336URI
-
https://doi.org/10.1016/j.jtct.2023.09.019DOI
Kompletterande språkuppgifter
-
Språk:engelska
-
Sammanfattning på:engelska
Ingår i deldatabas
Klassifikation
-
Ämneskategori:ref swepub-contenttype
-
Ämneskategori:art swepub-publicationtype
Anmärkningar
-
Outcomes following allogeneic hematopoietic cell transplantation (allo-HCT) for chronic myeloid leukemia (CML) with post-transplantation cyclophosphamide (PTCy) using an unrelated donor (UD) or a mismatched related donor (MMRD) remain unknown. We report a retrospective comparison of PTCy-based allo-HCT from a UD, non-PTCy allo-HCT from a UD, and PTCy allo-HCT from an MMRD. Inclusion criteria were adult patients with CML undergoing first allo-HCT between 2012 and 2019 from a UD with either PTCy or non-PTCy graft-versus-host disease (GVHD) prophylaxis or from an MMRD using PTCy. The primary endpoint was GVHD-free/relapse-free survival (GRFS). A total of 1341 patients were included (82% in the non-PTCy UD cohort). With a median follow-up of 34.9 months, the 3-year GRFS was 43% in the non-PTCy cohort, 37% in the PTCy-UD cohort, and 39% PTCy-MMRD cohort (P = .15). Multivariable analyses revealed no significant differences among the 3 cohorts in terms of overall survival (OS), progression-free survival, RI, and nonrelapse mortality. Factors independently associated with worse OS in the overall cohort were Karnofsky Performance Status <90 (hazard ratio [HR], 1.86; 95% confidence interval [CI], 1.41 to 2.45; P < .001), older age (HR, 1.24, 95% CI, 1.11 to 1.38; P < .001), and disease stage (compared to chronic phase [CP] 1): blast phase (HR, 2.25; 95% CI, 1.60 to 3.16; P < .001), accelerated phase (HR, 1.63; 95% CI, 1.05 to 2.54; P = .03), and CP >2 (HR, 1.58; 95% CI, 1.15 to 2.17; P = .005). These results suggest that allo-HCT in patients with CML using either a UD or an MMRD with PTCy-based GVHD prophylaxis are feasible transplantation, platforms and that the disease stage at allo-HCT remains a major prognostic factor, highlighting the importance of closely monitoring CML patients and proposing transplantation when indicated when still in CP1.
Ämnesord och genrebeteckningar
Biuppslag (personer, institutioner, konferenser, titlar ...)
-
Gras, LuukEBMT Stat Unit, Leiden, Netherlands.
(författare)
-
Koster, LindaEBMT Leiden Study Unit, Leiden, Netherlands.
(författare)
-
Kulagin, AleksanderPavlov Univ, RM Gorbacheva Res Inst, St Petersburg, Russia.
(författare)
-
Byrne, JennyUniv Nottingham, Nottingham, England.
(författare)
-
Apperley, Jane F.Imperial Coll, London, England.
(författare)
-
Halaburda, KazimierzInst Hematol & Transfus Med, Warsaw, Poland.
(författare)
-
Blau, Igor WolfgangCharite Univ Med Berlin, Berlin, Germany.
(författare)
-
Clark, AndrewBeatson West Scotland Canc Ctr, Glasgow, Lanark, Scotland.
(författare)
-
Kröger, NicolausUniv Hosp Eppendorf, Hamburg, Germany.
(författare)
-
Griskevicius, LaimonasVilnius Univ Hosp, Vilnius, Lithuania.
(författare)
-
Carlson, KristinaUniv Hosp, Uppsala, Sweden(Swepub:uu)krica965
(författare)
-
Collin, MatthewNorthern Ctr Bone Marrow Transplantat, Newcastle Upon Tyne, Tyne & Wear, England.
(författare)
-
Bloor, AdrianChristie NHS Trust Hosp, Manchester, Lancs, England.
(författare)
-
Raiola, Anna MariaIRCCS Osped Policlin San Martino, Genoa, Italy.
(författare)
-
Blaise, DidierProgramme Transplantat & Therapie Cellulaire, Marseille, France.
(författare)
-
Aljurf, MahmoudKing Faisal Specialist Hosp & Res Ctr, Riyadh, Saudi Arabia.
(författare)
-
López-Corral, LuciaHosp Univ Salamanca, Dept Hematol, IBSAL, CIBERONC, Salamanca, Spain.
(författare)
-
Sakellari, IoannaGeorge Papanicolaou Gen Hosp, Thessaloniki, Greece.
(författare)
-
Beguin, YvesUniv Liege, Liege, Belgium.;CHU Liege, Liege, Belgium.
(författare)
-
Wrobel, TomaszWroclaw Med Univ, Wroclaw, Poland.
(författare)
-
de Rosa, LucaOsped S Camillo Forlanini, Rome, Italy.
(författare)
-
de Lavallade, HughesGuys & St Thomas NHS Fdn Trust, London, England.
(författare)
-
Hayden, Patrick J.Trinity Coll Dublin, St Jamess Hosp, Dublin, Ireland.
(författare)
-
McLornan, DonalUniv Coll Hosp, London, England.
(författare)
-
Chalandon, YvesUniv Geneva, Hop Univ Geneva, Div Hematol, Geneva, Switzerland.;Univ Geneva, Hop Univ Geneve, Fac Med, Geneva, Switzerland.
(författare)
-
Yakoub-Agha, IbrahimUniv Lille, CHU Lille, INSERM, U1286,Infinite, F-59000 Lille, France.
(författare)
-
Vall dHebron Univ Hosp, Vall dHebron Inst Oncol, Dept Hematol, Barcelona, Spain.EBMT Stat Unit, Leiden, Netherlands.
(creator_code:org_t)
Sammanhörande titlar
-
Ingår i:Transplantation and Cellular Therapy: Elsevier30:1, s. 93.e1-93.e122666-63752666-6367
Internetlänk
Hitta via bibliotek
Till lärosätets databas
- Av författaren/redakt...
-
Ortí, Guillermo
-
Gras, Luuk
-
Koster, Linda
-
Kulagin, Aleksan ...
-
Byrne, Jenny
-
Apperley, Jane F ...
-
visa fler...
-
Halaburda, Kazim ...
-
Blau, Igor Wolfg ...
-
Clark, Andrew
-
Kröger, Nicolaus
-
Griskevicius, La ...
-
Carlson, Kristin ...
-
Collin, Matthew
-
Bloor, Adrian
-
Raiola, Anna Mar ...
-
Blaise, Didier
-
Aljurf, Mahmoud
-
López-Corral, Lu ...
-
Sakellari, Ioann ...
-
Beguin, Yves
-
Wrobel, Tomasz
-
de Rosa, Luca
-
de Lavallade, Hu ...
-
Hayden, Patrick ...
-
McLornan, Donal
-
Chalandon, Yves
-
Yakoub-Agha, Ibr ...
-
visa färre...
- Om ämnet
-
- MEDICIN OCH HÄLSOVETENSKAP
-
MEDICIN OCH HÄLS ...
-
och Klinisk medicin
-
och Hematologi
- Artiklar i publikationen
-
Transplantation ...
- Av lärosätet
-
Uppsala universitet